Viewing nowEsomeprazole Magnesium Trihydrate 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Hwa Il Pharmaceutical Co., Ltd.

MFDS item code 201907479 · Approved 2019.10.28 · Insurance code 684501800
Treatment and prevention of acid-related disorders (including reflux disease), ulcers and Helicobacter pylori infection, and gastrointestinal problems caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease, particularly for long-term maintenance therapy in erosive reflux esophagitis, and is effective for relief of symptoms in gastroesophageal reflux disease without esophagitis. It is also used in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. Additionally, it is used for the treatment of upper gastrointestinal symptoms and gastric ulcers related to NSAID use, as well as for preventing ulcer recurrence. It helps in treating Zollinger-Ellison syndrome and preventing rebleeding from gastric or duodenal ulcers. Overall, it is used to improve various symptoms and complications related to gastrointestinal diseases.
Adults Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. Adults may take 20 mg once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. For eradication of Helicobacter pylori, administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into two doses. After initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection, administer 40 mg once daily for 4 weeks. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. Older adults: No dose adjustment is necessary.
Adolescents aged 12 years and older Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.
This medication should not be administered to specific patients. For example, it should not be used in patients with known allergies to this medication or its components, including benzimidazole derivatives, or those who have previously shown such reactions. Care should also be taken in patients who are taking amoxicillin or clarithromycin for the eradication of Helicobacter pylori, in case of allergies to these antibiotics. This medication should particularly not be given to patients taking specific heart-related medications or those with a history of myocardial infarction, and to nursing mothers. This medication contains the dye E102, and those with sensitivity or allergy history to this component should use it cautiously. Various adverse reactions may occur while taking this medication, with common symptoms including headache, abdominal pain, diarrhea, and nausea; rare occurrences of blood disorders or severe allergic reactions may also arise. Long-term use may result in electrolyte imbalance, such as hypomagnesemia, necessitating regular check-ups. Furthermore, as this medication reduces gastric acid, the risk of bacterial infections in the gastrointestinal tract may increase, and the risk of fractures may heighten, so caution is advised in patients at risk of osteoporosis. There are many drug interactions with this medication; when taken with digoxin, warfarin, methotrexate, etc., strict adherence to the physician's instructions is required, and it is advisable not to use it in conjunction with certain antiviral medications. During pregnancy, the safety has not been fully established, thus it should be used cautiously; it is recommended not to use this medication during breastfeeding. In cases of overdose, as there are no specific antidotes, symptoms should be monitored and proper treatment should be administered. Lastly, this medication should be kept out of the reach of children and should not be transferred to another container to maintain its quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternum pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movement, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disorder, tremor, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbance, loss of taste, taste alteration, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, skeletal muscle necrosis, erythematous lupus, systemic lupus erythematosus, hypocalcemia, hypokalemia, rigidity, arrhythmia, seizure
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. The storage temperature should be room temperature between 1 and 30 degrees Celsius.
Pale pink round film-coated tablet
28 tablets (14 tablets/PTP X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Hwa Il Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.